Cancer Therapy News and Research

RSS

Hitachi and CLB in Lyon-France announce research collaboration to fight against cancer with AI

Hitachi, Ltd. and Centre Leon Berard (CLB), a leading French Comprehensive Cancer Center in Lyon-France, announced today that they have entered into an agreement to jointly promote research and development aimed at improving the efficiency of diagnosis and treatment of cancer and established a new research laboratory called Hitachi Lyon Lab on the CLB site, starting November 5th.

8 Nov 2019

New model could predict response of HIV-infected individuals to cancer immunotherapy

A group of researchers at UPF and the Marchuk Institute of Numerical Mathematics in Moscow, Russia, have designed a mathematical model to predict the response of HIV-infected individuals to a type of cancer immunotherapy.

7 Nov 2019

Hitachi and CLB establish new research laboratory to improve diagnosis, treatment of cancer

Hitachi, Ltd. and Centre Leon Berard, a leading French Comprehensive Cancer Center in Lyon-France, announced today that they have entered into an agreement to jointly promote research and development aimed at improving the efficiency of diagnosis and treatment of cancer and established a new research laboratory called Hitachi Lyon Lab on the CLB site, starting November 5th.

6 Nov 2019

Diminished taste function in cancer patients associated with reduced appetite

The simple pleasure of tasting and savoring food is "an important part of anyone's daily life," says University of Massachusetts Amherst sensory scientist Alissa Nolden.

6 Nov 2019

Nanotechnologies can lead to big advances in cancer therapy

Nami Therapeutics Corporation, which gets its name from the Mandarin word for "nano," is committed to using nanotechnologies to make big advances in cancer therapy.

6 Nov 2019

Gene-editing technique CRISPR trialed for first time as cancer treatment

The go-ahead has been given for the first trials using CRISPR as an alternative therapy for treating cancer.

6 Nov 2019

Study reveals key mechanism that helps cells to adapt to low-nutrient conditions

Scientists from the UNC School of Medicine and Stanford University have uncovered what may be a fundamental biological mechanism that helps organisms adapt to rapid changes to nutrients in their environments.

6 Nov 2019

Chiral interactions could be leveraged to improve the performance of drug-delivery nanoparticles

MIT engineers have shown that they can enhance the performance of drug-delivery nanoparticles by controlling a trait of chemical structures known as chirality -- the "handedness" of the structure.

6 Nov 2019

Penn researchers tag CAR T cells with imaging markers to monitor cancer therapy

With CAR T cell therapy, a patient's own immune cells are genetically modified and inserted back into the body to find and kill cancer. This form of immunotherapy has already revolutionized some cancer treatments, but once the CAR T cells are inside a patient, where do they go? How do doctors know that they have successfully reached their target and that they are continuing to fight disease weeks, months, or even years later?

5 Nov 2019

Wake Forest Baptist receives $6 million to study non-pharmaceutical cancer pain management

For many people who've had cancer, severe pain can persist even after treatment ends.

5 Nov 2019

Researchers identify potential drug targets for glioblastoma

Researchers at Karolinska Institutet in Sweden have identified 10 tumor-specific potential drug targets for the brain tumor glioblastoma. The results are presented in the scientific journal Cell Reports.

5 Nov 2019

UK aims to lead with cutting-edge radiation therapy

The UK is all set to launch its run into the future as the undisputed leader in the field of personalized and effective radiation therapy. The proposal is undergirded by a whopping £56 million, which will be used to set up and fund advanced radiation therapy research by a new collaborative setup, Cancer Research UK RadNet, over five years. This is the largest sum ever invested by this organization into radiotherapy research.

4 Nov 2019

Study describes a molecular strategy that helps prevent development of tumors in mice

The body's process for manufacturing fatty acids is regulated by the enzyme FASN. In normal cells, this is not a very active process - except occasionally in the liver and adipose tissue - since most of the fatty acids we need for cell maintenance are obtained from the diet.

4 Nov 2019

Kidney damage common in patients receiving immunotherapy for cancer, study finds

A new study indicates that kidney damage is fairly common in patients who take immunotherapy medications for treating cancer. The findings, which appear in an upcoming issue of CJASN, will be important for maintaining the kidney health of patients who are prescribed these drugs.

31 Oct 2019

Mount Sinai hosts Fourth Annual Prostate Cancer Research Gala

The Department of Urology at the Icahn School of Medicine at Mount Sinai will host its Fourth Annual Prostate Cancer Research Gala on Wednesday, November 6, at Cipriani 42nd Street.

31 Oct 2019

Optometrists reduce opioid prescription without increasing pain

Optometrists at the University of Michigan have introduced a new approach to prescribing opioids in an effort to help curb the nation’s opioid epidemic.

31 Oct 2019

Drug delivery still has great development potential

Nanocapsules and other containers can transport drugs through a patient's body directly to the origin of the disease and release them there in a controlled manner. Such sophisticated systems are occasionally used in cancer therapy. Because they work very specifically, they have fewer side effects than drugs that are distributed throughout the entire organism.

30 Oct 2019

New grant funds innovative approach to bladder cancer treatment

The San Antonio Medical Foundation has awarded Texas Biomedical Research Institute Professor Jordi B. Torrelles, Ph.D., with a $173,000 grant to study a modified Mycobacterium bovis Bacillus Calmette et Guérin (BCG) vaccine shown to have promise for treating bladder cancer.

30 Oct 2019

Research finds disparities in receiving recommended treatment for lung cancer

Only about 6 in 10 lung cancer patients in the United States receive the minimal lung cancer treatments recommended by the National Comprehensive Cancer Network guidelines, according to new research published online in the Annals of the American Thoracic Society.

30 Oct 2019

Bortezomib drug helps re-balance disrupted muscle growth, prevent contractures

When children experience brachial plexus injury at birth, or are born with cerebral palsy, some of the most disabling problems that follow are muscle contractures, or tightness of muscles, that severely restrict limb function.

29 Oct 2019

Cancer Therapy News and Research

Hitachi and CLB in Lyon-France announce research collaboration to fight against cancer with AI

New model could predict response of HIV-infected individuals to cancer immunotherapy

Hitachi and CLB establish new research laboratory to improve diagnosis, treatment of cancer

Diminished taste function in cancer patients associated with reduced appetite

Nanotechnologies can lead to big advances in cancer therapy

Gene-editing technique CRISPR trialed for first time as cancer treatment

Study reveals key mechanism that helps cells to adapt to low-nutrient conditions

Chiral interactions could be leveraged to improve the performance of drug-delivery nanoparticles

Penn researchers tag CAR T cells with imaging markers to monitor cancer therapy

Wake Forest Baptist receives $6 million to study non-pharmaceutical cancer pain management

Researchers identify potential drug targets for glioblastoma

UK aims to lead with cutting-edge radiation therapy

Study describes a molecular strategy that helps prevent development of tumors in mice

Kidney damage common in patients receiving immunotherapy for cancer, study finds

Mount Sinai hosts Fourth Annual Prostate Cancer Research Gala

Optometrists reduce opioid prescription without increasing pain

Drug delivery still has great development potential

New grant funds innovative approach to bladder cancer treatment

Research finds disparities in receiving recommended treatment for lung cancer

Bortezomib drug helps re-balance disrupted muscle growth, prevent contractures

Event guide: 7th Allogeneic Cell Therapies Summit eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News